Gelatin methacryloyl hydrogel as a potential scaffold for cell transplantation for Huntington’s disease

Clicks: 28
ID: 322689
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #47 of 197 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 197 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Cell replacement therapy is a promising strategy for treating Huntington’s disease. Advances in cell reprogramming now allow the generation of clinically relevant cells; however, conventional delivery methods can compromise long-term cell survival and maturation. Hydrogels have emerged as supportive three-dimensional scaffolds that better mimic the in vivo environment. This study examined whether encapsulating human-induced lateral ganglionic eminence precursor cells (hiLGEPs) in gelatin methacryloyl (GelMA) hydrogel enhanced differentiation after transplantation into the striatum of the quinolinic acid lesion rat model of Huntington’s disease. hiLGEPs were delivered either in cell culture medium (n = 5) or in a pre-crosslinked GelMA solution (n = 4) prior to transplantation. GelMA was polymerised in situ using a visible-light optical fibre system, and grafts were assessed 4 weeks later. Transplanted cells survived in all animals. Notably, GelMA-encapsulated hiLGEPs produced significantly more protein gene product 9.5 (PGP9.5+) neurons than those delivered in cell culture medium. Transplanted cells in both groups differentiated into microtubule-associated protein 2 (MAP2+) and GABA+ phenotypes, with no detectable differences in graft volume. These findings provide the first evidence that encapsulating hiLGEPs in GelMA enhances early neuronal differentiation following transplantation, supporting GelMA hydrogel as a promising delivery scaffold for cell replacement therapy in Huntington’s disease.
Reference Key
openalex_W7171359424 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag295
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.